
Tobra-day ®
Tobra-day ® contains tobramycin sulfate equivalent to 500 mg tobramycin base in water for injections to 5 mL. Sulfuric acid and sodium hydroxide may be added to adjust pH. Contains no preservatives.
For once daily intravenous use in the treatment of cystic fibrosis patients (>5 years old) with acute pulmonary exacerbations caused by susceptible organisms. This product may be put to uses other than that disclosed in the Product Information, which uses may be protected by patents.
Strength500 mg in 5 mL |
Package5 mL solution in 7 mL vial |
Pack Size10 vials |
Phebra CodeINJ093 |
Please log in to place an order
Product Information
Consumer Medicine Information
Material Safety Data Sheet
